Martin Pulé
Founder at AUTOLUS THERAPEUTICS PLC
Net worth: 4 M $ as of 30/03/2024
Profile
Martin Pulé is the founder of Autolus Therapeutics Plc, where he currently holds the title of Chief Scientific Officer & Senior Vice President.
Autolus Therapeutics Plc was founded in 2014.
Dr. Pulé is also the founder of Autolus Ltd.
Dr. Pulé's education history includes an undergraduate degree from University College Dublin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AUTOLUS THERAPEUTICS PLC
0.42% | 28/02/2023 | 698,741 ( 0.42% ) | 4 M $ | 30/03/2024 |
Martin Pulé active positions
| Companies | Position | Start |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Founder | 31/08/2014 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Founder | - |
Training of Martin Pulé
| University College Dublin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Martin Pulé
